The selling is modest and typical of routine director transactions; no material negative signal is evident. Monitor for continuation of selling or any open-market purchases by executives.
Price Chart
Executive Summary
Two directors at Recursion Pharmaceuticals sold a combined $217K in shares over a 7-day window, with no open-market buying. The CFO also had a tax withholding transaction, surrendering shares worth $149K. Total insider selling represents less than 0.1% of market cap, indicating routine activity.
Key Financial Metrics
Key Facts
- Director Borgeson Blake sold 30,000 shares for $93,000 at $3.10 per share on 2026-04-07.
- Director Gibson Christopher sold 40,000 shares for $124,000 at $3.10 per share on 2026-04-07.
- Gibson Christopher also converted derivative securities (two separate 40,000-share conversions) with zero cash proceeds.
- CFO Ben R. Taylor surrendered 48,028 shares worth $149,367.08 to cover tax obligations related to equity compensation.
- Total open-market sales by insiders: $217K, representing less than 0.1% of the $1.7B market cap.
Financial Impact
$217,000 in net open-market sales, less than 0.1% of market cap
Risk Factors
- Continued director selling could signal waning confidence if volume increases.
- Non-cash transactions (conversions, tax withholdings) do not reflect market sentiment but may dilute shareholders over time.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RXRX-1775681943136 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | 424B5 | $3.47 $3.58 | ▼ −3.32% | ▼ −3.23% | $3.80 (−9.67%) |
Oct 15, 2026 11d ago | 8-K | $4.16 $3.58 | ▼ −13.94% | ▼ −12.93% | $3.80 (−8.65%) |
Oct 15, 2026 11d ago | Press Release | $4.16 $3.58 | ▼ −13.94% | ▼ −12.93% | $3.80 (−8.65%) |
Oct 15, 2026 11d ago | Press Release | $4.16 $3.58 | ▲ +13.94% | ▲ +12.93% | $3.80 (+8.65%) |
Oct 15, 2026 11d ago | Press Release | $4.16 $3.58 | ▼ −13.94% | ▼ −12.93% | $3.80 (−8.65%) |
Oct 15, 2026 11d ago | 424B5 | $4.16 $3.58 | ▲ +13.94% | ▲ +12.93% | $3.80 (+8.65%) |
Oct 6, 2026 20d ago | 144 | $4.63 $3.84 | ▼ −17.17% | ▼ −17.03% | $3.80 (−17.93%) |
Oct 6, 2026 20d ago | 144 | $4.63 $3.84 | ▼ −17.17% | ▼ −17.03% | $3.80 (−17.93%) |
Sep 21, 2026 5w ago | 8-K | $3.97 $3.70 | ▼ −6.80% | ▼ −5.78% | $3.80 (−4.28%) |
Sep 10, 2026 6w ago | Insider Cluster | $3.20 $3.83 | ▲ +19.69% | ▲ +20.03% | $3.80 (+18.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers